SequelSEC

InfuSystem Holdings, Inc INFU

Surgical & Medical Instruments & Apparatus · CIK 0001337013 · Fiscal year ends 1231

Revenue
$143.44M
Fiscal year ended 2025-12-31
Operating income
$11.92M
Fiscal year ended 2025-12-31
Free cash flow
$23.85M
Fiscal year ended 2025-12-31

Valuation, from the filing

Public float$122.27MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$6.05Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income18.4×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue0.9×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity2.1×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

Valuation over time

18.4× earnings today, against a median of 58.4× across 7 years on record. Below its own history.

Float measuredPublic floatFloat / net income
2025-06-30$122.27M18.4×
2024-06-28$137.02M58.4×
2023-06-30$190.57M218.5×
2022-06-30$172.31M9572.7×
2021-06-30$370.28M260.8×
2020-06-30$150.74M8.7×
2019-06-30$52.43M38.5×

Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Effective tax rate37.6%94th
CapEx / revenue0.4%6th
FCF margin16.6%89th
Net margin4.6%77th
Operating margin8.3%77th
Revenue YoY growth6.4%31th
Current ratio1.80x31th
SBC / revenue3.0%34th
Long-term debt / equity0.34x36th
Gross margin56.0%39th

InfuSystem Holdings, Inc (INFU) reported revenue of $143.44M and net income of $6.63M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from InfuSystem Holdings, Inc’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

InfuSystem Holdings, Inc income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$143.44M$134.86M$125.78M$109.91M$102.38M$97.39M$81.12M$67.14M$71.08M$70.50M
Cost of revenue$63.14M$64.46M$62.68M$49.35M$43.85M$38.63M$34.23M$27.57MUnavailableUnavailable
Gross profit$80.30M$70.40M$63.11M$60.56M$58.54M$58.76M$46.88M$39.57MUnavailableUnavailable
Operating income$11.92M$6.89M$4.09M$1.65M$2.82M$8.83M$3.52M$415.00K-$3.81M$974.00K
Net income$6.63M$2.34M$872.00K$18.00K$1.42M$17.33M$1.36M-$1.10M-$20.71M-$222.00K
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 21.10Mshares 21.71Mshares 21.65Mshares 21.55Mshares 22.05Mshares 21.72Mshares 20.84Mshares 21.42Mshares 22.74Mshares 22.62M
Pretax income$10.62M$5.06M$1.85M$130.00K$1.26M$7.54M$1.52M-$1.04M-$5.26M-$364.00K
Income tax expense$4.00M$2.71M$979.00K$112.00K-$163.00K-$9.79M$163.00K$53.00K$15.45M-$142.00K
Diluted EPS$0.31$0.11$0.04$0.00$0.06$0.80$0.07$-0.05$-0.91$-0.01
Selling, general & administrative$67.46M$62.52M$58.03M$56.41M$51.45M$44.86M$38.92M$34.51M$35.00M$34.29M
General & administrative$56.97M$51.21M$45.38M$44.15M$40.68M$35.20M$28.99M$25.40M$25.23M$24.63M
Selling & marketing$10.49M$11.31M$12.65M$12.26M$10.78M$9.66M$9.93M$9.11M$9.78M$9.66M

Balance

InfuSystem Holdings, Inc balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalents$3.19M$527.00K$231.00K$165.00K$186.00K$9.65M$2.65M$4.32M$3.47M$3.40M
Total assets$100.56M$103.61M$102.92M$99.39M$97.59M$96.99M$79.22M$64.07M$68.88M$96.34M
Current assets$36.34M$32.16M$30.62M$24.78M$22.06M$29.77M$19.30M$17.54M$17.67M$20.77M
Total liabilities$43.23M$46.08M$50.61M$51.38M$49.31M$56.24M$56.89M$43.63M$37.93M$45.66M
Current liabilities$20.18M$17.66M$15.71M$14.47M$12.90M$23.00M$21.85M$14.79M$12.47M$16.44M
Total equity incl. NCI$57.33M$57.53M$52.30M$48.00M$48.27M$40.75M$22.33M$20.44M$30.95M$50.69M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$5.39M$6.53M$6.40M$4.82M$3.94M$3.00M$2.90M$2.25M$1.76M$2.17M
Accounts receivable$22.90M$21.20M$19.83M$16.87M$15.40M$14.72M$12.10M$9.59M$11.28M$11.58M
Goodwill$3.71M$3.71M$3.71M$3.71M$3.71M$0UnavailableUnavailableUnavailableUnavailable
Long-term debt$19.62M$23.86M$29.10M$33.16M$32.75M$29.38M$30.30M$28.84M$25.35M$26.58M
Accounts payable$10.82M$9.85M$8.01M$8.34M$7.86M$6.78M$7.96M$7.09M$5.52M$5.32M

Cash flow

InfuSystem Holdings, Inc cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flow$24.41M$20.46M$11.22M$17.52M$18.32M$20.28M$13.88M$11.39M$7.72M$7.91M
Capital expenditures$560.00K$1.09M$1.02M$982.00K$980.00K$1.09M$2.93M$281.00K$104.00K$168.00K
Investing cash flow-$6.79M-$13.24M-$6.73M-$11.48M-$21.32M-$12.16M-$19.64M-$4.98M$918.00K-$5.34M
Financing cash flow-$14.96M-$6.92M-$4.42M-$6.06M-$6.46M-$1.12M$4.10M-$5.56M-$8.56M$15.00K
Net change in cash$2.66M$296.00K$66.00K-$21.00K-$9.46M$7.00M-$1.67M$849.00K$71.00K$2.58M
Stock-based compensation$4.36M$4.46M$4.07M$3.82M$6.40M$2.61M$997.00K$957.00K$682.00K$462.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchases$9.87M$1.18M$153.00K$5.46M$560.00K$0$0$10.40MUnavailable$75.00K
Depreciation & amortization$13.29M$12.50M$12.51M$13.36M$14.62M$14.02M$12.34M$11.31MUnavailableUnavailable

Derived

InfuSystem Holdings, Inc derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flow$23.85M$19.37M$10.20M$16.54M$17.34M$19.19M$10.95M$11.11M$7.61M$7.74M
Gross margin56.0%52.2%50.2%55.1%57.2%60.3%57.8%58.9%61.0%63.5%
Operating margin8.3%5.1%3.2%1.5%2.8%9.1%4.3%0.6%-5.4%1.4%
FCF margin16.6%14.4%8.1%15.0%16.9%19.7%13.5%16.5%10.7%11.0%
SBC / revenue3.0%3.3%3.2%3.5%6.3%2.7%1.2%1.4%1.0%0.7%
Current ratio1.80x1.82x1.95x1.71x1.71x1.29x0.88x1.19x1.42x1.26x
Revenue YoY growth6.4%7.2%14.4%7.4%5.1%20.1%20.8%-5.5%0.8%Unavailable
Net margin4.6%1.7%0.7%0.0%1.4%17.8%1.7%-1.6%-29.1%-0.3%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue0.4%0.8%0.8%0.9%1.0%1.1%3.6%0.4%0.1%0.2%
Long-term debt / equity0.34xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate37.6%53.6%52.9%86.2%-13.0%-129.8%10.7%UnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open INFU in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-04View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-04View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2017-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2016-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.